Manulife (Manufacturers Life Insurance)’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-14,653
Closed -$68 3220
2021
Q4
$68 Sell
14,653
-5,749
-28% -$27 ﹤0.01% 3081
2021
Q3
$174K Buy
20,402
+1,915
+10% +$16.3K ﹤0.01% 3030
2021
Q2
$303K Buy
18,487
+1,356
+8% +$22.2K ﹤0.01% 2804
2021
Q1
$378K Buy
17,131
+1,526
+10% +$33.7K ﹤0.01% 2464
2020
Q4
$483K Buy
15,605
+1,002
+7% +$31K ﹤0.01% 2220
2020
Q3
$297K Buy
14,603
+3,959
+37% +$80.5K ﹤0.01% 2304
2020
Q2
$166K Buy
+10,644
New +$166K ﹤0.01% 2580